-
1
Discovery of novel favipiravir derivatives with improved pharmacokinetic properties as anti-SFTSV agents
Published 2024-12-01Subjects: Get full text
Article -
2
Navigating from cellular phenotypic screen to clinical candidate: selective targeting of the NLRP3 inflammasome
Published 2024-12-01Subjects: Get full text
Article